You are here

Article Text

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Phase 2 study of pembrolizumab in patients with advanced rare cancers

http://dx.doi.org/10.1136/jitc-2019-000347corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Naing A, Meric-Bernstam F, Stephen B, et al. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J ImmunoTher Cancer 2020;8:e000347. doi: 10.1136/jitc-2019-000347

    In the article titled 'Phase 2 study of pembrolizumab in patients with advanced rare cancers', the author name Abulrahman Abonofal is spelt incorrectly. The correct spelling is Abdulrahman Abonofal.